Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04087057 · ClinicalTrials.gov registry record
Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT04087057: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT04087057 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04087057 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This trial studies the barriers associated with timely chemotherapy given after surgery (adjuvant) in patients with invasive breast cancer. Meeting with patients and asking questions may help doctors to learn about factors that can cause delays in the start of chemotherapy after surgery in patients with breast cancer.
Primary Outcome
Will be analyzed using an open code method by identifying and classifying interview data. Qualitative analysis will be done in partnership with a qualitative research consulting group (ResearchTalk, Inc.). Transcripts of the semi-structured interviews will be de-identified by removing 18 protected health information (PHI) identifiers from the transcripts.
Interventions
- OTHER Medical Chart Review
- OTHER Interview
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-08-23 |
| Est. Completion | 2024-04-16 |
What the finished NCT04087057 record still lists
NCT04087057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Medical Chart Review is the first listed.
NCT04087057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04087057 about?
NCT04087057 is a clinical study titled "Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer". This trial studies the barriers associated with timely chemotherapy given after surgery (adjuvant) in patients with invasive breast cancer. Meeting with patients and asking questions may help doctors to learn about factors that can cause delays in the start of chemotherapy after surgery in patients ...
What is the current status of trial NCT04087057?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2019-08-23. Estimated completion is 2024-04-16.
What interventions are being tested in trial NCT04087057?
The interventions under investigation include: Medical Chart Review (OTHER), Interview (OTHER), Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT04087057?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI